Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01189123 · ClinicalTrials.gov registry record · NA
Cell Mediated Immunity in Older Adults
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
NCT01189123: Completed NA study, sponsored by Vanderbilt University.
NCT01189123 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 105 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01189123, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
Study Summary
This study is to study the immune response to the flu vaccine in people 65 years old and older. Only adults 65 years old and older and who are getting their flu vaccine are being asked to join in this study. The investigators plan to enroll approximately 100 people in this study in the 2010-2011 flu season. Vanderbilt is working with the Centers for Disease Control and Prevention on this study. There will be 5 study visits. Up to 4 tablespoons of blood from a vein will be obtained prior to the flu shot. Return visits will be 1, 2, and 4 weeks later,with up to 4 tablespoons of blood drawn again. Patients will be randomized to receive either the standard dose or the high dose flu vaccine. Both flu vaccines are FDA-approved.
Primary Outcome
comparison of CMI in high vs standard dose
Interventions
- BIOLOGICAL High dose influenza vaccine Sanofi-Pasteur
- BIOLOGICAL fluzone by sanofi pasteur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT01189123 record still lists
NCT01189123 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which High dose influenza vaccine Sanofi-Pasteur is the first listed.
NCT01189123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01189123 about?
NCT01189123 is a clinical study titled "Cell Mediated Immunity in Older Adults". This study is to study the immune response to the flu vaccine in people 65 years old and older. Only adults 65 years old and older and who are getting their flu vaccine are being asked to join in this study. The investigators plan to enroll approximately 100 people in this study in the 2010-2011 flu...
What is the current status of trial NCT01189123?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2010-08. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01189123?
The interventions under investigation include: High dose influenza vaccine Sanofi-Pasteur (BIOLOGICAL), fluzone by sanofi pasteur (BIOLOGICAL).
Who is sponsoring clinical trial NCT01189123?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01189123's enrollment target sits among peer trials
105 834th of 2000 higher than 1,165 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia